GSK bullish on 2023 as earnings surpass… GSK posted robust quarterly earnings that beat expectations on the back of sales of its shingles vaccine and…
Elliott portfolio manager behind GSK and… The Elliott Management investor behind activist campaigns at UK healthcare giant GSK and Germany’s Fresenius…
GSK hails respiratory virus jab after positive… GSK trial results appeared to show that its potential blockbuster vaccine for respiratory syncytial virus is…
AstraZeneca succeeds in last-ditch bid to stop… AstraZeneca has succeeded in an eleventh-hour effort to stop a former senior executive from joining rival…
GSK vaccine chief aims to break dominance of… GSK and Sanofi are setting their sights on ending the dominance of BioNTech/Pfizer and Moderna vaccines,…
AstraZeneca sues former executive over move to… AstraZeneca has sued a former top business development executive to delay him taking a job at rival GSK,…
GSK raises profit guidance after strong sales of… GSK has raised its full-year revenue and profit guidance after soaring sales of its shingles vaccine helped…
GSK spin-off Haleon becomes world’s biggest… GSK’s consumer health spin-off Haleon has become the largest London listing in more than a decade on its…
GSK split will help deal with ‘perennial… GlaxoSmithKline chief executive Emma Walmsley said the imminent spin-off of the consumer health division…
GSK investor support for spin-off vindicates… GlaxoSmithKline’s chief executive said a shareholder vote in favour of spinning off its consumer healthcare…